Different effects of TCBPA exposure on liver cancer cells and liver cells: two sides of the coin

Tetrachlorobisphenol A (TCBPA), widely used as a substitute for tetrabromobisphenol A (TBBPA), has been detected in various environmental media.Therefore, a detailed evaluation of the toxicological properties of TCBPA is necessary.In this study, we used hepatoma and normal liver cell models in vitro to investigate the effects of TCBPA.Our findings indicate that TCBPA promotes the proliferation of liver cancer cells, as evidenced by MTT and EdU assays, and enhances the expression levels of molecules related to hepatoma proliferation.Further investigation into the molecular mechanism revealed that TCBPA-induced hepatoma proliferation is regulated by an NLRP3-mediated inflammatory process.Additionally, TCBPA was found to promote the epithelial-mesenchymal transition (EMT) process in liver cancer cells.Conversely, TCBPA inhibited the proliferation of normal liver cells.Mechanistic studies showed that TCBPA induced cell pyroptosis in normal liver cells by evaluating a series of related markers, including NLRP3, IL-1β, ASC, GASDMD, and Caspase 1.In vivo models further showed that TCBPA causes liver tissue damage.In summary, this study demonstrates that TCBPA has a dual effect: promoting the occurrence and development of liver tumor cells in vitro, while inhibiting the proliferation of normal liver cells, like two sides of a coin.These opposite cellular outcomes are regulated by NLRP3-mediated inflammatory processes, providing valuable insights for evaluating the potential health impacts of TCBPA.